Literature DB >> 22386017

A lung cancer molecular prognostic test ready for prime time.

Yang Xie1, John D Minna.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22386017      PMCID： PMC3382084          DOI： 10.1016/S0140-6736(12)60154-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  Non-small-cell lung cancer mRNA expression signature predicting response to adjuvant chemotherapy.

Authors:  Yang Xie; John D Minna
Journal:  J Clin Oncol       Date:  2010-09-07       Impact factor: 44.544

Review 2.  Gene expression-based prognostic signatures in lung cancer: ready for clinical use?

Authors:  Jyothi Subramanian; Richard Simon
Journal:  J Natl Cancer Inst       Date:  2010-03-16       Impact factor: 13.506

3.  Microarrays: retracing steps.

Authors:  Kevin R Coombes; Jing Wang; Keith A Baggerly
Journal:  Nat Med       Date:  2007-11       Impact factor: 53.440

Review 4.  Tumor mRNA expression profiles predict responses to chemotherapy.

Authors:  John D Minna; Luc Girard; Yang Xie
Journal:  J Clin Oncol       Date:  2007-10-01       Impact factor: 44.544

5.  Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.

Authors:  James P Sullivan; Monica Spinola; Michael Dodge; Maria G Raso; Carmen Behrens; Boning Gao; Katja Schuster; Chunli Shao; Jill E Larsen; Laura A Sullivan; Sofia Honorio; Yang Xie; Pier P Scaglioni; J Michael DiMaio; Adi F Gazdar; Jerry W Shay; Ignacio I Wistuba; John D Minna
Journal:  Cancer Res       Date:  2010-11-30       Impact factor: 12.701

6.  Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

Authors:  Chang-Qi Zhu; Keyue Ding; Dan Strumpf; Barbara A Weir; Matthew Meyerson; Nathan Pennell; Roman K Thomas; Katsuhiko Naoki; Christine Ladd-Acosta; Ni Liu; Melania Pintilie; Sandy Der; Lesley Seymour; Igor Jurisica; Frances A Shepherd; Ming-Sound Tsao
Journal:  J Clin Oncol       Date:  2010-09-07       Impact factor: 44.544

7.  Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancer.

Authors:  Aik T Ooi; Vei Mah; Derek W Nickerson; Jennifer L Gilbert; Vi Luan Ha; Ahmed E Hegab; Steve Horvath; Mohammad Alavi; Erin L Maresh; David Chia; Adam C Gower; Marc E Lenburg; Avrum Spira; Luisa M Solis; Ignacio I Wistuba; Tonya C Walser; William D Wallace; Steven M Dubinett; Lee Goodglick; Brigitte N Gomperts
Journal:  Cancer Res       Date:  2010-08-15       Impact factor: 12.701

8.  Predicting the future for people with lung cancer.

Authors:  Yang Xie; John D Minna
Journal:  Nat Med       Date:  2008-08       Impact factor: 53.440

9.  An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.

Authors:  Paul Roepman; Jacek Jassem; Egbert F Smit; Thomas Muley; Jacek Niklinski; Tony van de Velde; Anke T Witteveen; Witold Rzyman; Arno Floore; Sjaak Burgers; Giuseppe Giaccone; Michael Meister; Hendrik Dienemann; Marcin Skrzypski; Miroslaw Kozlowski; Wolter J Mooi; Nico van Zandwijk
Journal:  Clin Cancer Res       Date:  2009-01-01       Impact factor: 12.531

10.  Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer.

Authors:  Yangsik Jeong; Yang Xie; Guanghua Xiao; Carmen Behrens; Luc Girard; Ignacio I Wistuba; John D Minna; David J Mangelsdorf
Journal:  PLoS Med       Date:  2010-12-14       Impact factor: 11.069
View more
  8 in total

1.  A Prognostic Model to Predict Mortality among Non-Small-Cell Lung Cancer Patients in the U.S. Military Health System.

Authors:  Jie Lin; Corey A Carter; Katherine A McGlynn; Shelia H Zahm; Joel A Nations; William F Anderson; Craig D Shriver; Kangmin Zhu
Journal:  J Thorac Oncol       Date:  2015-12       Impact factor: 15.609

2.  The impact of a fourteen-gene molecular assay on physician treatment decisions in non-small-cell lung cancer.

Authors:  Shane Dormady; Michael S Broder; Girish V Putcha; Robert H Dumanois; Alison H DeCristofaro; Eunice Chang; Paul R Billings; Thierry Jahan
Journal:  Int J Clin Oncol       Date:  2014-06-06       Impact factor: 3.402

3.  Adaptive prediction model in prospective molecular signature-based clinical studies.

Authors:  Guanghua Xiao; Shuangge Ma; John Minna; Yang Xie
Journal:  Clin Cancer Res       Date:  2013-12-09       Impact factor: 12.531

4.  Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.

Authors:  Bailiang Li; Yi Cui; Maximilian Diehn; Ruijiang Li
Journal:  JAMA Oncol       Date:  2017-11-01       Impact factor: 31.777

5.  Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer.

Authors:  Christopher R S Banerji; Simone Severini; Carlos Caldas; Andrew E Teschendorff
Journal:  PLoS Comput Biol       Date:  2015-03-20       Impact factor: 4.475

6.  BARD1 serum autoantibodies for the detection of lung cancer.

Authors:  Maxim Pilyugin; Pascaline Descloux; Pierre-Alain André; Viktoria Laszlo; Balazs Dome; Balazs Hegedus; Sylvain Sardy; Samuel Janes; Andrea Bianco; Geoffrey J Laurent; Irmgard Irminger-Finger
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

7.  Dynamic changes of circulating tumour DNA in surgical lung cancer patients: protocol for a prospective observational study.

Authors:  Kezhong Chen; Heng Zhao; Fan Yang; Bengang Hui; Tianyang Wang; Lieu Tu Wang; Yanbin Shi; Jun Wang
Journal:  BMJ Open       Date:  2018-02-06       Impact factor: 2.692

8.  An individualized immune prognostic signature in lung adenocarcinoma.

Authors:  Liangdong Sun; Gening Jiang; Diego Gonzalez-Rivas; Peng Zhang
Journal:  Cancer Cell Int       Date:  2020-05-07       Impact factor: 5.722
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.